VolitionRx Limited Board of Directors

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.

Mr. Cameron Reynolds MBA

Mr. Cameron Reynolds MBA

Founder, CEO, President & Director

Dr. Andrew Retter MBBS

Dr. Andrew Retter MBBS

Chief Medical Officer

Dr. Salvatore Thomas Butera DVM

Dr. Salvatore Thomas Butera DVM

Chief Executive Officer of Volition Veterinary Diagnostics Development LLC

Mr. Nicholas Plummer

Mr. Nicholas Plummer

Group General Counsel

Ms. Sharon Ballesteros

Ms. Sharon Ballesteros

U.S. Head of Quality & Development Process

Mr. Gael Forterre M.B.A.

Mr. Gael Forterre M.B.A.

Chief Commercial Officer

Dr. Gaetan Michel Ph.D.

Dr. Gaetan Michel Ph.D.

Chief Operating Officer

Ms. Louise Batchelor Day

Ms. Louise Batchelor Day

Group Chief Marketing & Communications Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.